Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neurogene (NGNE) Return on Assets: 2019-2025

Historic Return on Assets for Neurogene (NGNE) over the last 3 years, with Sep 2025 value amounting to -0.30%.

  • Neurogene's Return on Assets rose 11.00% to -0.30% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.30%, marking a year-over-year increase of 11.00%. This contributed to the annual value of -0.27% for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Neurogene's Return on Assets is -0.30%, which was down 5.60% from -0.28% recorded in Q2 2025.
  • Neurogene's Return on Assets' 5-year high stood at -0.25% during Q1 2025, with a 5-year trough of -0.96% in Q2 2023.
  • Moreover, its 3-year median value for Return on Assets was -0.34% (2023), whereas its average is -0.41%.
  • Data for Neurogene's Return on Assets shows a peak YoY skyrocketed of 61bps (in 2024) over the last 5 years.
  • Over the past 3 years, Neurogene's Return on Assets (Quarterly) stood at -0.34% in 2023, then increased by 3bps to -0.30% in 2024, then grew by 11bps to -0.30% in 2025.
  • Its last three reported values are -0.30% in Q3 2025, -0.28% for Q2 2025, and -0.25% during Q1 2025.